You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNMT1

Showing 1 - 25 of 104
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DNA Methylation and Histone Modification in H. Pylori Associated

Recruiting
  • Gastric Carcinoma
  • Immunohistochemical staining for DNMT1 and EZH2
  • Assiut, Egypt
    Assiut University
Mar 31, 2023

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Birmingham (NTX-301)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 6, 2021

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022

People Who Have Genetic Changes and Features of Autism: Simons

Recruiting
  • 16P11.2 Deletion Syndrome
  • +184 more
    • New York, New York
    • +1 more
    Jan 6, 2023

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Active, not recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +5 more
    • Tucson, Arizona
    • +16 more
    Oct 19, 2022

    Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Mesothelioma
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 1, 2023

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

    Terminated
    • Advanced Solid Tumor
    • +3 more
    • Darlinghurst, New South Wales, Australia
    • +1 more
    Dec 18, 2022

    MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

    Recruiting
    • Myelodysplastic Syndromes
    • MDS/MPN Crossover Syndromes
    • Cleveland, Ohio
      Cleveland Medical Center, University Hospitals Seidman Cancer Ce
    Aug 10, 2022

    Tumors, Solid Tumors Trial run by the NCI (TdCyd)

    Suspended
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2022

    Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

    Completed
    • Neoplasms
    • FdCyd + THU
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Mar 1, 2023

    Obesity, Lupus Erythematosus Trial in Sao Paulo (Vitamin B12 + folic acid supplementation, Placebo supplementation)

    Not yet recruiting
    • Obesity
    • Lupus Erythematosus
    • Vitamin B12 + folic acid supplementation
    • Placebo supplementation
    • Sao Paulo, Brazil
      Univsersity of Sao Paulo
    Oct 15, 2021

    Newly Diagnosed Peripheral T-cell Lymphoma Trial in Nanjing (CMOP+Chidamide)

    Recruiting
    • Newly Diagnosed Peripheral T-cell Lymphoma
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Jun 1, 2023

    Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)

    Not yet recruiting
    • Polycystic Ovary Syndrome
    • laparoscopy / laparotomy
    • NO INTERVENTION
    • Hyderabad, Telangana, India
      Dr. Shraddha Ramchandani
    Oct 25, 2023

    Vulvar Intraepithelial Neoplasia Grade 2, Vulvar Intraepithelial Neoplasia Grade 3 Trial (VTD-101 ointment)

    Not yet recruiting
    • Vulvar Intraepithelial Neoplasia Grade 2
    • Vulvar Intraepithelial Neoplasia Grade 3
    • VTD-101 ointment
    • (no location specified)
    Feb 3, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +3 more
    • Biopsy
    • +4 more
    • (no location specified)
    Jan 4, 2023

    Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)

    Recruiting
    • Sickle Cell Disease
    • NDec - oral decitabine-tetrahydrouridine
    • +2 more
    • Oakland, California
    • +39 more
    Jan 24, 2023

    Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Los Angeles (dietary supplement,

    Completed
    • Adenocarcinoma of the Prostate
    • +6 more
    • green tea extract
    • +4 more
    • Los Angeles, California
    • +1 more
    Jun 22, 2021

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +5 more
    • Decitabine and Cedazuridine
    • Nivolumab
    • New York, New York
      NY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
    Jul 8, 2022

    Chronic Myelomonocytic Leukemia, de Novo MDS, MDS Trial in Cleveland (other, drug, genetic)

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +7 more
    • flow cytometry
    • +7 more
    • Cleveland, Ohio
    • +1 more
    Feb 21, 2019

    Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • Leukemia
    • Tampa, Florida
    • +4 more
    Nov 11, 2022

    Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

    Withdrawn
    • Castration Levels of Testosterone
    • +8 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 31, 2021

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Clonal Hematopoiesis of Indeterminate Potential in Venous

    Active, not recruiting
    • Venous Thromboembolism
      • Nîmes, France
        CHU de Nimes
      Jan 24, 2022